// Reference=MNI
// (1) Asensio, 2015: controls > alcohol patients, GM
// Subjects=24
-2	55	-2
5	19	48

// (2) Brooks, 2014: Healthy > Alcohol (without CTQ)// Subjects=5864	-21	10-65	-18	8

// (3) Chanraud, 2009: Controls > Alcohol-Dependent Subjects
// Subjects=24
15	-32	2-45	-6	5752	-3	513	-36	30-40	39	3358	-32	5048	-40	52-15	-33	0-52	8	3951	30	3257	22	2452	-40	52-66	-24	4-8	57	33

// (4) Dalwani, 2011: Controls > Alcohol Patients
// Subjects=25
-53	5	3212	-58	-2-39	-68	-4039	-68	-39

// (5) Demirakca, 2011: Controls > Alcohol-Dependent Patients
// Subjects=50
-46	-10	-646	10	-420	-16	-2420	4	-1656	-22	-6-4	-32	444	30	346	50	-46	44	12

// (6) Grodin, 2013: HC > Pure Alcoholics
// Subjects=37
18	-56	1462	-26	-2418	40	4420	-26	424	-6	60-50	56	38-28	-2	48-52	10	24-24	50	1042	-60	32-16	-56	58-22	-70	60	36	3226	-32	50-8	-16	-214	-6	46-26	-14	-626	-16	-6

// (6) Grodin, 2013: HC > Polysubstance Abusing Alcoholics
// Subjects=37
0	24	4662	-8	-3234	20	52-28	22	5038	10	-360	-10	24-44	4	24

// (7) Howell, 2013: Healthy Volunteers > Binge Drinkers 
// Subjects=19
16.5	-66	2136	-64.5	10.5

// (8) Jang, 2007: Controls > Alcohol-Dependent Patients
// Subjects=20
.29	25.84	26.47
-53.87	-56.38	-.33
-43	-17.56	12.45
-54.87	-13.14	14.46
-51.66	-63.71	1.48
9.82	44.08	14.42
43.1	56.89	.26
67.26	-21.11	14.29
63.05	8.19	29.39
63.48	4.38	-22.91
64.73	4.56	-9.5
-.84	40.73	25.02

// (9) Mechtcheriakov, 2006: Controls > Alcohol Addiction Patients
// Subjects=22
6	-13	15-7	-13	1532	-34	-5-28	-45	-457	-7	34-57	-11	3145	12	32-41	16	28-44	27	2542	-19	10-37	20	740	-47	-51-42	-48	-51

// (10) Momenan, 2012: Healthy Controls > Alcoholics 		 
// Subjects=130
19.22	5.66	54.78
44.51	-7.28	12.24
50.88	1.42	32.69
16.29	-66.55	47.54
-21.01	15.93	38.78

// (11) Rando, 2011: Healthy Comparison Subjects > Alcohol-Dependent Patients
// Subjects=45
51	40	19-5	1	508	-58	18

// (12) Segobin, 2014: Controls > Alcohol-Dependent Patients
// Subjects=19
-5	-12	-19-45	-44	-2645	8	-72	3	52

// (13) Trick, 2014: C>P, alcohol 
// Subjects=17
70.45	12.5	17.6363.4	-49.37	45.165.97	14.76	45.444.39	-11.59	2.5346.3	17.16	-11.55

// (14) van Eijk, 2013: Healthy Controls > Alcohol-Dependent Patients
// Subjects=49
-9	-25	45-45	-13	4951	15	3032	-82	-35-39	-12	1339	-18	1224	35	39-32	-84	-36-22	-70	43-15	42	4564	-4	-11-27	54	198	-73	-36-54	18	339	6	634	-10	6760	-31	132	-76	-5433	-72	30

// (15) van Holst, 2012: AUDs < HCs
// Subjects=36
-23	-12	72-29	-19	3030	-60	56-29	-61	5145	-46	3633	5	2-9	-18	3-29	-3	6

// (16) Yoon, 2017: AUD < control
// Subjects=20
26	-60	-51
-24	-62	-52

// (17) Wiers, 2015: ADP < control
// Subjects=22
-48	11	10
-51	12	24
-26	-7	63
-45	-67	-51
18	-64	59
-12	-78	12

// (18) Chanraud, 2007: AD < control
// Subjects=26
-44	-7	54
40	-1	54
0	25	34
-42	-9	2
-64	-22	4
-39	-28	10
-9	-3	10
8	-3	10
8	-35	-4
-48	-60	-47

// (19) Nurmedov, 2016: AUD < control
// Subjects=24
-34.5	45	-12
-31.5	31.5	-9
-31.5	55.5	1.5
-12	60	21
-7.5	61.5	-19.5
-25.5	46.5	24
7.5	42	-22.5
18	67.5	9
-3	49.5	3
3	-21	43.5
1.5	28.5	-13.5
-25.5	-10.5	-18
-28.5	1.5	-27
-33	-10.5	-22.5
31.5	0	-25.5
27	-7.5	-19.5
18	-3	-10.5
-57	-3	-16.5
-58.5	-16.5	-10.5
-51	-1.5	-42
-58.5	-9	-34.5
-54	10.5	-27
-64.5	-22.5	-24
54	12	-27
67.5	-39	4.5
55.5	-46.5	10.5
52.5	-6	-34.5
-39	-18	48
-12	-57	57
21	-94.5	21
-40.5	-64.5	-52.5
12	-52.5	-9
18	-48	-13.5
10.5	-63	-9
25.5	-60	-58.5
18	-63	-60
12	18	-10.5

// (20) Zois, 2017: ADP < control
// Subjects=95
11	-28	43
-2	-6	45
0	20	36
2	32	28
-56	-7	34
-45	-15	48
-41	-21	57
42	-15	48
41	-4	57
2	45	13
47	-12	7
-32	18	3
-48	3	39
-23	42	25
45	9	31
42	0	-18
35	3	-18
-39	-19	0
35	23	1
2	-33	49

// (21) Wang, 2016: ADP < control
// Subjects=20
2	-19	49
-3	20	33
3	33	25
0	15	51
3	-1	55
-51	-13	45
5	36	-14
-5	-67	10
-30	12	3
-48	11	25
6	-66	-41

// (1) Almeida, 2008: NS > S (all smokers)		// Subjects=39		-4	-51	2720	-69	2240	-13	45-34	-21	5120	-19	14

// (2) Almeida, 2011: NS > S (unsuccessful quiters)		// Subjects=228		16	-20	106	-10	810	-72	-4818	-86	-34-4	-68	-48-28	-56	58-36	-58	44

// (3) Brody, 2004: NS > S (all smokers)		// Subjects=19		24	42	3216	50	328	62	2834	6	4820	34	5232	18	54-32	40	36-52	30	1616	-56	-26

// (4) Franklin, 2014: NS > S (all smokers)		// Subjects=80		4	-18	22	36	-30-40	-70	-4230	-50	-50

// (5) Fritz, 2014: NS > S (all smokers)		// Subjects=315		15	62	0-42	11	6-14	68	18	46	014	62	3-14	64	036	51	-514	64	-2-8	62	-158	46	-2-14	64	-212	63	-28	46	0-39	12	0-36	-12	46	23	-14

// (6) Galliant, 2006: NS > S (all smokers)		 // Subjects=22		7.95	9.06	30.2418.37	-24.42	-6.9648.19	-67.59	34.91.73	-3.23	48.3714.62	-73.75	28.24-32.77	16.49	-25.83-55.35	-23.26	-24.87-8.49	46.67	20.08-11.83	-34	-4.38-57.16	-23.96	2.1235.27	15.46	-29.13-8.07	-83.71	26.25-47.81	-26.29	57.116.52	-73.48	8.01-1.44	19.89	-25.58-13.74	-87.94	4.35-7.32	-53.36	6.42

// (7) Hanlon, 2014: NS > S (all smokers)		// Subjects=58		-22	2	-20-10	56	-15-7	-25	133	5	-2030	51	-1133	-15	-5

// (8) Kuhn, 2010: NS > S (all smokers)		 // Subjects=22		-2.05	27.02	-29.64

// (9) Kuhn, 2012: NS > S (all smokers)		// Subjects=33		32	-71	-32

// (10) Liao, 2010: NS > S (all smokers)		 // Subjects=44		-22.58	-34.68	0.35-10.04	43.13	-17.65-3.21	31.51	6.92

// (11) Morales, 2012: NS > S (all smokers)		// Subjects=25		18	38	-15

// (12) Stoeckel, 2015: NS > S (all smokers)		// Subjects=16		-34	22	14

// (13) Wang, 2014: NS > S (all smokers)		// Subjects=22		34	13	-36	-10	910	48	30

// (14) Yu, 2011: NS > S (GM, univariate results)		// Subjects=16		-34	-46	-4426	-40	-46

// (15) Zhang, 2011: NS > S (high pack year smokers)		// Subjects=48		-24	-46	32

// (16) Shen, 2017: nicotine smoker < nonsmoker
// Subjects=85
-9	52.5	-21
46.5	42	6
-6	-6	33
-49.5	-55.5	-36
31.5	-70.5	-30

// (17) Peng, 2018: mild/moderate smoker < nonsmoker
// Subjects=53
-32	-69	12
-6	-67.5	15
-8	-52	-2
6	-65	19
-17	-57	15
11	15	13
-8	8	10
42	0	1.5

// (17) Peng, 2018: severe smoker < nonsmoker
// Subjects=53
-29	-70	0
25.5	-66	9
-9	-61.5	12
-46.5	-7.5	-9
-41	11	-8
55.5	18	4.5
35	30	3
59	0	3
56	-33	4
-10.5	-51	34.5
9	-52.5	-15
37.5	-4.5	13.5
28.5	6	-30
-57	-24	0
44	-75	25
-64.5	-9	-7.5
41	-75	39
-7.5	-64.5	40.5
-3	-49.5	7.5
30	-88.5	4.5
-21	-99	-1.5
15	-22.5	-1.5
-16.5	-28.5	-3
7.5	-61.5	-16.5

// (1) Gardini, 2012: Heroin abusers < controls		 
// Subjects=24
54.13	-33.19	18.39

// (2) Li, 2014: Heroin dependent individuals vs healthy controls		 
// Subjects=17
-31.31	13.99	55.18
-10.59	16.08	63.9
40.37	-12.34	-.93
15.69	26.59	28.4
67.22	-15.39	-2.99

// (3) Lin, 2012: heroin users on methadone vs control		// Subjects=27		-17	-78	-27-17	20	-28

// (4) Liu, 2009: Heroin-dependent subjects vs healthy subjects		// Subjects=10		21	56	41-4	15	613	7	31-1	14	28

// (5) Lyoo, 2006: Opiate-dependent subjects vs healthy controls		 
// Subjects=32
-20.3	69.49	-17.06
-26.42	50.69	38.65
-4.36	53.55	-3.85
7.21	56.91	-19.69
32.73	6.08	-26.35
-42.07	-19.15	20.22
42.38	-3.02	13.07
56.98	34.75	-9.58
31.67	53.99	32.53
-54.7	-59.44	-15.79
-42.38	57	6.13
57.02	9.37	-27.82
-35.99	10.15	-36.21

// (6) Qiu, 2013: Heroin-dependent individuals vs matching controls		 
// Subjects=20
11.67	36.3	39.41
-4.19	35.76	32.88
-23.32	52.58	17.42
-40.11	27.5	23.67
49.72	20.89	23.59
30.73	25.82	37.8
36.21	-62.07	-2.83

// (7) Reid, 2008: Opiate-dependent subjects vs controls		// Subjects=9		8	-14	10-6	-18	10-14	-24	14

// (8) Wang, 2012: Heroin-dependent patients and normal subjects		// Subjects=20		33	53	-515	-15	700	-45	1021	23	40-44	-82	-17

// (9) Yuan, 2009: opiate addiction vs Healthy Group		 
// Subjects=15
-38.23	56.26	-23.81
-57.14	42.74	-.58
50.99	-38.33	20.98
38.01	36.93	11.47
4.1	29.67	-33.34
-42.26	26.6	9.32
45.5	-28.37	-39.6
-4.26	20.38	-11.57
25.32	20.56	-12.86
-7.5	43.8	-7.6
30.89	-92.81	-56.19

// (10) Keihani, 2017: heroin < control
// Subjects=18
26	-6	2
-26	-6	2
19.5	36	5

// (11) Cheng, 2015: controls > heroin
// Subjects=33
-36	-76	-15
20	-28	9
3	-4	43
-41	-1	45
-29	0	63
-24	21	52
-44	0	-3
-57	-6	4
-33	3	4
65	-15	37
62	-3	34
11	50	9
14	54	16
11	51	0
50	-67	28

// (12) Wang, 2016: FHD < control
// Subjects=30
2	-63	20

// (1) Alia-Klein, 2011: cocaine use disorders vs. controls
// Subjects=40		-22	24	-1636	20	2750	-53	235	-12	-1631	2	-18

// (2) Barros-Loscertales, 2011: Cocaine-dependent patients and healthy controls
// Subjects=20		49	19	2538	27	4130	58	24-41	32	3125	41	40-18	2	-17-11	-49	4023	-5	-2431	7	-26-47	-72	25-43	-18	132	-38	-33

// (3) Crunelle, 2014: cocaine users < controls 		// Subjects=30		-33	23	37

// (4) Daumann, 2011: Amphetamine < Drug-naÃ¯ve		// Subjects=13		-2	48	-22-2	50	282	52	-166	48	0

// (5) Franklin, 2002: Cocaine-dependent group < control group		// Subjects=13		36	12	036	6	-8-34	20	06	40	-12-8	48	188	50	060	-26	10-50	2	-4

// (6) Gardini, 2012: controls vs. cocaine users		 
// Subjects=14
-25.99	-83.44	18.98
26.51	-16.34	-12.56
43.48	-20.5	3.16

// (7) Hanlon, 2011: cocaine users < current users		// Subjects=17		10	66	2-28	34	4416	8	-16-42	26	-6-28	10	-2216	20	60	-62	-44

// (8) Ide, 2014: healthy controls vs. cocaine dependent		// Subjects=55		37	0	-37-2	-24	4421	-60	-34-27	9	62-35	-23	61-36	7	-4328	3	629	-65	297	-63	7-5	-68	2612	-6	7149	-2	10-33	25	-26-29	-50	53-54	-11	41-14	21	6446	-77	10-39	-39	-3525	-44	58

// (9) Jan, 2012: controls > methamphetamine users		// Subjects=12		-12	14	660	12	60-2	-38	52

// (10) Kim, 2006: methamphetamine users < controls 		 
// Subjects=11
31.6	56.97	12.35

// (11) Mackey, 2014: Amphetamine-type/cocaine < controls		 
// Subjects=101
25.6	-71.27	-30.99
53.18	-33.98	57.3
-23.25	16.36	-5.63

// (11) Mackey, 2014: Amphetamine use over lifetime		 
// Subjects=101
-38.8	-22.41	52.61

// (12) Morales, 2012: Control non-smoker > Methamphetamine-dependent smoker	// Subjects=20		26	54	12-24	41	-23-14	0	58-40	3	-3-42	-10	4050	-3	3469	-24	-610	-48	66-3	10	14	-34	42

// (13) Moreno-Lopez, 2012: prefrontal gray matter reductions in cocaine dependent
// Subjects=38		-26	18	-17-20	57	-3-48	-25	-37	33	-1512	12	-346	-26	12-9	27	-1328	21	-159	19	-156	-1	3-33	-7	-1952	-19	23-56	-14	-18

// (14) Schwartz, 2010: meth users < controls 	// Subjects=61		-44	-7.8	-0.436.6	-39	32.22.8	64	-42.144.8	1.5	2.7

// (15) Sim, 2007: Cocaine-dependent subjects < healthy controls		 
// Subjects=27
20.2	30.23	59.76
-5.27	51.34	46.25
18.93	60.63	22.17
57.01	14.96	-22.66
50.68	-5.69	-48.95
-60.2	-18.68	-38.53
-16.72	-31.71	.95
14.05	-90.35	-30.73
-15.54	-90.6	-30.54

// (16) Van Wingen, 2013: healthy controls vs.  ADHD plus cocaine dependence	// Subjects=10		27	2	623	-60	-45

// (17) Tanabe, 2009: Controls > SDI		// Subjects=19		-5	53	-3

// (18) Bouso, 2015: DMT users < Controls		 
// Subjects=22
37.2	-8.66	42.34
45.46	23.4	13.46
10.92	-40.06	50.19
-23.25	40.45	26.01
-2.9	-37.53	24.58
-32.34	-72.31	29.35

// (19) Liao, 2011: Ketamine < Controls		// Subjects=41		28	5	62-2	5	54

// (20) Qiu, 2014: codeine users < Controls		 
// Subjects=28
-7.54	34.83	-33.63

// (21) Parvaz, 2017: control > CUD
// Subjects=19
-17	-77	20
23	-54	33

// (22) Yip, 2017: CUD < control
// Subjects=37
-48	18	28

// (23) Yuan, 2017: control > betel quid
// Subjects=25
18	58	-4
56	28	0
-20	28	-16
-6	16	-42

// (24) Garza-Villarreal, 2018: CA < HC
// Subjects=47
-60	5	9
-43	47	12
-45	-16	55
-61	-51	11
-44	8	-6
-44	31	33
-7	24	32
-50	37	-3
-54	-57	35
-8	62	21
-27	11	59
-54	4	38
-39	24	47
-23	44	40
-27	59	12
-45	15	-11
-6	40	48
-43	-56	53
-9	43	47
-62	-30	23
-42	2	55
-28	44	35
-43	18	47
-5	63	-7
-49	43	-4
-4	47	-3
-35	-39	67
-41	42	24
-24	64	0
-36	-90	3
-35	-67	56
-24	-102	1
-47	24	35
-10	38	51
-39	-63	58
-29	20	-24
-9	68	10
-23	59	21
-6	56	34
-61	-4	20
-59	-38	42
-7	59	13
-24	-47	-15
-9	-78	0
-48	53	-1
-15	-103	6
-4	40	13
-6	50	28
-47	7	48
-5	59	4
-5	34	23
-31	-12	72
-51	-33	34
-5	35	21
-46	-51	-22
-26	-95	-13
-47	-29	62
-38	23	-15
27	61	5
37	54	12
56	11	9
5	62	8
18	32	52
9	54	36
19	30	53
30	56	15
28	40	37
25	38	44
57	13	16
46	45	3
48	31	29
31	46	31
45	38	23
10	50	41
26	50	29
51	32	23
63	-21	30
40	30	40
51	-45	39
20	50	37
4	61	-10
59	6	8
21	47	39
11	41	-16
46	24	37
44	14	2
27	-100	8
60	7	25
58	-8	8
45	49	-2
60	-5	-12
42	-9	-8
64	-36	8
7	-48	43
0	60	-9
54	32	11
53	34	14
6	58	18
23	65	13
56	21	10
41	21	-2
20	-72	-11
69	-10	-19
60	-56	-1
43	-21	51
56	-1	40
59	6	-4
59	-31	-20
43	-22	65
39	-90	-4
45	56	-13
4	-21	54
42	11	-16

// (25) Ruan, 2018: 6 month abs meth < control
// Subjects=30
5	-61	59
3	6	0
-26	-31	-20
30	-69	-50

// (1) Battisella, 2014: cannabis users < controls		// Subjects=25		-22	14	-14-50	10	-14-56	2	-28-48	10	-32-36	8	-10-26	10	-4250	14	-2064	-10	-2046	14	-3424	6	-3612	-54	16		// (2) Fibley, 2014: marijuana users < controls 		// Subjects=75		26	54	-8-16	58	-10

// (3) Gilman, 2014: controls > marijuana users		// Subjects=20		32	54	636	-16	4830	20	58-20	68	-6-32	8	-48-48	-6	-128	-66	66

// (4) Lopez-Larson, 2011: controls > marijuana users 		 
// Subjects=18
34	-22.07	13.31
23.36	23.01	44.69
31.82	17.62	41.68
-8.43	38.81	31.59
-34.76	-13.09	-2.44

// (5) Matochick, 2005: marijuana users < controls 		// Subjects=11		22	-18	-10

// (6) Welch, 2013: cannabis consumers < cannabis non-consumers	// Subjects=23		-35	-8	-24-18	55	42

// (7) Wetherill, 2015: healthy controls > cannabis users 		// Subjects=19		2	-16	6-26	-4	226	-16	64
// (8) Hill, 2016: controls > cannabis
// Subjects=34
2	-78	-12
-3	42	19
5	32	24
53	-28	22

// (9) Yip, 2014: cannabis < healthy
// Subjects=20
51	-1	28
18	-49	67